Biogen
BIIB
BIIB
982 hedge funds and large institutions have $32.7B invested in Biogen in 2022 Q3 according to their latest regulatory filings, with 150 funds opening new positions, 276 increasing their positions, 369 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.2% more ownership
Funds ownership: 82.76% → 84.97% (+2.2%)
8% more call options, than puts
Call options by funds: $2.02B | Put options by funds: $1.87B
25% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 369
Holders
982
Holding in Top 10
21
Calls
$2.02B
Puts
$1.87B
Top Buyers
| 1 | +$326M | |
| 2 | +$179M | |
| 3 | +$134M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$120M |
| 5 |
Millennium Management
New York
|
+$88.4M |
Top Sellers
| 1 | -$307M | |
| 2 | -$165M | |
| 3 | -$106M | |
| 4 |
Renaissance Technologies
New York
|
-$105M |
| 5 |
HM
HealthCor Management
New York
|
-$91.8M |